Crystal structures are reported for the D85S and D85S/F219L mutants of the light-driven proton/hydroxyl-pump bacteriorhodopsin. These mutants crystallize in the orthorhombic C222 1 spacegroup, and provide the ®rst demonstration that monoolein-based cubic lipid phase crystallization can support the growth of well-diffracting crystals in non-hexagonal spacegroups. Both structures exhibit similar and substantial differences relative to wild-type bacteriorhodopsin, suggesting that they represent inherent features resulting from neutralization of the Schiff base counterion Asp85. We argue that these structures provide a model for the last photocycle intermediate (O) of bacteriorhodopsin, in which Asp85 is protonated, the proton release group is deprotonated, and the retinal has reisomerized to all-trans. Unlike for the M and N photointermediates, where structural changes occur mainly on the cytoplasmic side, here the large-scale changes are con®ned to the extracellular side. As in the M intermediate, the side-chain of Arg82 is in a downward con®gur-ation, and in addition, a p-cloud hydrogen bond forms between Trp189 NE1 and Trp138. On the cytoplasmic side, there is increased hydration near the surface, suggesting how Asp96 might communicate with the bulk during the rise of the O intermediate.
Introduction
Bacteriorhodopsin is a 26 kDa heptahelical transmembrane protein that is found in extremely halophilic archeae like Halobacterium salinarum, and in eubacteria. 1 Photoisomerization of the all-trans retinal chromophore, covalently attached to Lys216 through a protonated Schiff base, to the 13-cis, 15-anti con®guration initiates ion translocation across the cell membrane, and establishes an electrochemical gradient for ATP synthesis and other energyrequiring membrane processes. The cyclic reaction, the``photocycle,``that follows the photoisomerization of the retinal produces distinct, spectroscopically identi®able photointermediates, which have been de®ned in kinetic and spectroscopic terms as BR 570 3 K 590 6 L 550 6 M 412 6 N 560 6 O 640 3 BR 570 (reviewed most recently in Biochim. Biophys. Acta 2000, volume 1460). Three decades of sitedirected mutagenesis, static and time-resolved spectroscopy, and low-resolution projection and 3D maps have revealed many details of the photocycle. However, understanding how the energy absorbed by the chromophore leads to unidirectional (vectorial) ion transport requires detailed structural descriptions of each photointermediate at the atomic level.
Using X-ray crystallography, signi®cant advances have been made recently in characterizing the structure of bacteriorhodopsin, and several of its photocycle intermediates. Crystals of BR grown in a cubic lipid phase 2 have been used to determine high-resolution structures of the lightadapted (``resting'') state protein at resolutions of 1.55 A Ê 3 and 1.9 A Ê . 4 Also described have been an early-M intermediate to 1.8 A Ê resolution (E204Q-mutant), 5 a late-M intermediate to 2.0 A Ê resolution (D96N-mutant) 6 , an M 2 intermediate to 2.25 A Ê resolution, 7 as well as an early intermediate of the WT protein trapped at low temperature, believed to be the K LT intermediate at 2.1 A Ê resolution. 8 A structure claimed to be the L intermediate has been published, 9 despite serious concerns based on spectra of the illuminated crystals showing signi®cant contamination from a later intermediate. 10 These publications also illustrate how various BR mutants acquire properties that differ markedly from those of the WT protein.
Mutants of Asp85 are of particular interest, because the critical step in the WT transport cycle is the protonation of this residue. Thus, mutants in which residue 85 does not carry a negative charge will resemble, from an electrostatic standpoint, speci®c photocycle intermediates. The D85N mutant, for example, exists as an equilibrium of three species: 11 a blue one at low pH, a purple one at pH 8-9, and a yellow one at high pH. These were proposed to be analogous to the O, the N, and the M intermediates, respectively. 11 Indeed, projection maps of the yellow state, 12 with deprotonated retinal Schiff base, exhibited the same kind of large-scale displacements of the transmembrane helices as those of the M intermediate of the WT. 13 Likewise, the purple state, with protonated Schiff base but deprotonated Asp96, was shown to contain 13-cis,15-anti retinal like the N intermediate 14 even without illumination. 15 Its resemblance to N includes the FTIR spectrum, with a large and characteristic shift of the amide I band. The blue state of D85N has not been examined as closely as the two others. It is similar to``acid blue BR'' at pH < 3, in which Asp85 is protonated, and the retinal is slightly distorted from an all-trans con®guration. 16 ± 18 A related property of certain BR Asp85 mutants is speci®c binding of a halide ion near the Schiff base. In halorhodopsin the equivalent residue is a threonine, and HR pumps chloride anions rather than protons. Furthermore, substituting serine or threonine for Asp85 converts BR to a HR-like chloride pump. 19, 20 The D85S mutant binds chloride with an af®nity approaching that of halorhodopsin (K D of 100 mM versus 40 mM), unlike the D85T mutant that exhibits much weaker binding. 19, 20 Binding of chloride causes a blue-shift from an O-like to a BR-like absorption maximum of the chromophore for both the D85S and D85T mutants. 19, 20 When soaked with halide ions, the orthorhombic blue crystals of the BR D85S mutant protein turn purple (i.e. bind chloride), and in the process become disordered and eventually dissolve. However, addition of halide prior to crystallization produces a purple protein that crystallizes in high phosphate buffer and forms small hexagonal plates similar to those of WT BR. These crystals are currently under investigation. 22 Because, like the O intermediate, 22 the mutants contain all-trans retinal (or more precisely a mixture of all-trans and the structurally similar 13-cis,15-syn, as in dark-adapted BR) with both Schiff base and Asp96 protonated and residue 85 neutral, they should be regarded as O-like intermediates and their structures are likely to reveal structural features that play a role at the end of the BR photocycle. While the D85N mutation is isosteric to protonated wild-type Asp85 and would therefore be the optimal mutant to study, the mutant protein bleaches in detergent and could not be crystallized.
We report here the crystal structures of the BR D85S and D85S/F219L mutants in the chloride-free state. Studies on the double mutant were carried out in anticipation of trapping a photocycle intermediate analogously to the use of the F219L mutant of wild type. 23 The two protein structures, crystallized at low salt concentrations and in the absence of halide ions, have been re®ned to resolutions of 2.25 A Ê and 2.0 A Ê , respectively. Reassuringly, in almost all respects, the maps for D85S/ F219L are identical to those for D85S with the exception of differences in the region near the mutated residue 219, as expected, but these will not be discussed here. The electron density suggests that the Schiff base is in the all-trans con®guration, hydrogen bonded to water 402, which in turn is hydrogen-bonding to the hydroxyl moiety of Ser85, although a certain fraction of 13-cis,15-syn chromophore cannot be excluded due to shape similarity. On the extracellular side, the side-chain of Arg82, a key residue in the WT photocycle, adopts a downward con®guration similar to that found in M-intermediates. 5 Furthermore, Trp138 and Trp189 exhibit signi®cant positional differences from the WT, leading to the formation of a p-cloud hydrogen bond that may play a role in stabilizing large helical displacements in the extracellular region relative to the WT. Near the cytoplasmic surface the increased number of water molecules in the D85S structure suggests that Asp96 is reprotonated from the bulk through an aqueous hydrogen-bonded network during the rise of the O intermediate.
Results and Discussion

Crystal packing
The D85S and D85S/F219L mutants were crystallized using the cubic lipid phase method, 2 which has been used successfully for BR and HR. The orthorhombic C222 1 spacegroup obtained here provides the ®rst demonstration that monoolein-based cubic lipid phase crystallization can support the growth of high-resolution crystals in non-hexagonal spacegroups and suggests that the cubic lipid phase method might have broader applications to membrane protein crystallization. These cubic lipid phase crystals are all composed of stacked lipid bilayers, which in the previous hexagonal forms contain BR trimers, but in this orthogonal form contain an up-down arrangement of tightly packed monomers. The A-C helices, instead of packing against lipids at the local 3-fold found in the hexagonal spacegroups, pack against the D-G helices in the a-c plane (Figure 1 ). Between layers, the monomers are packed extracellular-to-extracellular and cytoplasmic-to-cytoplasmic, contrary to the cytoplasmic-to-extracellular packing found in hexagonal BR cubic lipid phase-crystals. Interestingly, the P6 3 22 halorhodopsin crystals also pack extracellular-to-extracellular and cytoplasmic-to-cytoplasmic. BR crystals obtained by detergent-based crystallization have yielded the following spacegroups:
P622,
24 C2, 25 and P22 1 2 1 (2D crystals). 26 However, these forms, with the exception of the 2D crystals, contain trimeric arrangements of BR, unlike D85S where no trimers exist within the unit cell. Unfortunately, we were unable to measure the visible spectrum and the photocycle of the crystals because of their small size. The cytoplasmic-cytoplasmic crystal packing contacts provide the only intramolecular contacts between the ac layers stacked in the b direction (Figure 1(a) ). During the WT photocycle the E and F helices undergo large motions and such motion would likely affect this crystal-packing contact, causing crystal damage, as is observed upon the addition of halide.
Very speci®c archaeal lipid-protein interactions in BR have been observed 3 , showing a high degree of complementarity between the protein surface and the shape of the lipids. Although we noted the presence of diether lipids (native to the purple membrane) in the D85S structure, the data did not show a complete bilayer nor could we identify monoolein to be present in the crystals. In contrast, the cubic lipid phase-based HR crystal structure revealed monoolein molecules coexisting with native lipids. 27 Overall structure of D85S bacteriorhodopsin
The atomic model for the D85S mutant includes residues Glu9 to Gly63 and Ile78 to Glu232. (perpendicular to the bilayer), shows D85S BR monomers in one bilayer arranged in an up/ down motif forming head-to-tail dimers with clear lack of any trimeric arrangement. However, the packing density in the bilayer is comparable to that of the P6 3 form. View (c) down the c-axis is 90 rotated from view (a).
Bacteriorhodopsin D85S Crystal Structure
The seven transmembrane helices, inclusive of p-bulges, are de®ned as helix A (9-31), B (36-63), C (80-101), D (104-126; two residues shorter than WT), E (130-161; six residues longer than WT), F (164-192), and G (200-225; one residue shorter than WT). There are large helical displacements relative to the WT structure, located almost exclusively on the extracellular side ( Figure 2 ). When compared with WT, the helices tilt outward from the center of the protein with pivot points near their cytoplasmic ends, except for helix E with a pivot point near Ala143 (Table 1 ). In contrast, in the N-intermediate, helices E and F move outward on the cytoplasmic side, presumably in order for Asp96 to reprotonate, and helix G moves slightly towards the ground state position of helix F as described for the F219L BR mutant. 23 The removal of the Schiff base counter ion at position 85 in D85S, in the presence of an all-trans retinal, has a very different effect on the overall structure: helices F and G retain their resting state conformations whereas helix E shows a pronounced outward tilt in the extracellular region only. By the time the O intermediate is reached, the events on the cytoplasmic side are mostly over, and the closed cytoplasmic side of the D85S mutant is as expected for an O-like intermediate. However, large displacements on the extracellular side have not been previously observed. The O 3 BR transition is one of the slowest in the photocycle 28 , hinting at substantial structural rearrangements necessary to either restore the original hydrogen-bonding network of the ground state to allow reprotonation of the proton release group by Asp85, or, in the hydroxide pumping scheme 29, 30 the net transport of a hydroxide ion from the extracellular surface to the Schiff base region.
The BC loop, a two-stranded b-sheet, is disordered in D85S crystals. In the high-resolution ground-state WT structure, the BC loop rests against the cytoplasmic region of an adjacent monomer in the next layer whereas here, two BC loops point towards each other. The residues surrounding the BC loop are the ones most displaced from their WT positions (Figure 2(d) ). The previously reported p-bulge in helix G 3 is present, in addition to a second, larger p-bulge at the end of helix E (residues 152-155, Figure 3(a) ), which is also described in helix E of HR, 27 and present but not described in a previous BR WT structure. 25 The p-bulge of helix E is stabilized by local n 3 n 5 helical hydrogen bonding which causes its C terminus to point towards helix C. In contrast to the p-bulge in helix G that contains one main-chain carbonyl (Ala215) not hydrogen-bonded to the A four-residue perfect a-helix was successively aligned with the backbone atoms of our model, and the RMS deviation calculated. Plotted in (a) is the deviation from an ideal a-helix for WT BR, D85S BR, and halorhodopsin. For WT BR, all large deviations represent proline-induced kinks except for the p-bulge kink in helix G that is also present in D85S. D85S contains an additional non-proline p-bulge kink in the C-terminal half of helix E, which is also present in halorhodopsin. This p-bulge may be involved in allowing helix E to move outward for the M/N photointermediates. The hydrogen-bonding pattern for both helices E and G is illustrated in (b). The red arrows indicate n 3 n 5 hydrogen bonds and the green arrows indicate n 3 n 4 hydrogen bonds longer than 3.4 A Ê .
backbone, the p-bulge in helix E contains three such carbonyls (Figure 3(b) ).
It is very unlikely that the global structural differences from bacteriorhodopsin are the result of different crystal packing. In the presence of chloride, D85S grows only as purple, hexagonal, platelike crystals similar to wild-type bacteriorhodopsin (unpublished observations). In the absence of chloride, D85S does not crystallize under the standard crystallization conditions for BR, suggesting that there is a structural change induced by the lack of a negative charge near the Schiff base. Furthermore, N. pharaonis sensory rhodopsin II, which does have an anionic residue homologous to Asp85, crystallizes in a orthorhombic cell with packing similar to D85S, yet without helix tilts of the type described for D85S. 31 Another possible but unlikely cause for the large structural differences might be the volume reduction due to the aspartate to serine mutation at position 85.
Active site at the retinal and the extracellular region
The retinal of D85S BR adopts an all-trans con®guration (Figure 4) , although a fraction of 13-cis,15-syn cannot be excluded. The Schiff base forms a 2.67 A Ê hydrogen bond to water 402, which is hydrogen-bonded to the hydroxyl OG atom of D85S at 2.51 A Ê . Hydrogen bonds are present also between D85S-OG and the C1O of Arg82 (2.59 A Ê ) as well as the Trp86 backbone nitrogen (3.14 A Ê ). Water 402 is 1.12 A Ê closer to Ser85-OG in D85S than it is to Asp85 OD1 in the WT structure, likely due to the smaller volume of the mutated sidechain. At a distance of 3.44 A Ê and a non-optimal angle, Asp212 does not hydrogen-bond to water 402, yet is still ®rmly held by Tyr185 OH (2.44 A Ê ) and Tyr57 OH (2.69 A Ê ). The hydrogen-bonding network of protein side-chains and water molecules continues from Tyr57 down to the region of the proton release group. However, water molecules 401 and 406, involved in connecting the Schiff base to Arg82 through Asp85 in WT BR, are now both absent. Hence, the D85S mutation appears to have diminished the communication between the Schiff base and the proton release group. The CB-CD-CG atoms of Arg82 have moved toward the space occupied in the WT structure by water molecules 401 and 406. Furthermore, the a carbon of Arg82 is displaced outward by 1.75 A Ê . The guanidinium head group is in a downward con®guration like in M, 5 pointing towards the proton release group and forming hydrogen bonds to water molecules 403 (2.74 A Ê via NE), 405 (2.86 A Ê via NH2), and 407 (2.82 A Ê via NH1) ( Figure 5 ).
There is extensive evidence for coupling between the charge state of Asp85 and the protonation state of the proton release group in the WT protein 5,32 ± 34 and this coupling seems to exist also between the chloride-binding site in D85T and the proton Figure 4 . The retinal-binding region with a 2F o À F c composite annealed map contoured at 1s. The serine, replacing the native aspartate at position 85, is hydrogen-bonded to water 402, which itself is bonded to the Schiff base. In contrast to WT BR, water 402 is not bonding to Asp212. On the cytoplasmic side of the retinal, the p-bulge is evident, as is the well-de®ned water 501, bridging Trp182 NE1 and the backbone oxygen of Ala215. release group. 19 In both proteins a negative charge in one region precludes a negative charge in the other. One would expect from the coupling that in D85S, where residue 85 carries no charge (as in the M, N and O intermediates of WT photocycle), the proton release group is negatively charged, i.e. unprotonated. Two water molecules not found in the WT structure, 408 and 409, connect Arg82 to Thr205 and Glu204. It is likely that Arg82 is reacting to the different charge distribution and steric environment in D85S in order to stabilize the presumed negative charge of the proton release group. For the O intermediate this would suggest that Arg82 retains an M-like (downward) con®gur-ation until the O 3 BR transition, when Asp85 deprotonates and the proton release group reprotonates, therefore allowing Arg82 to return to its ground-state con®guration.
Late in the re®nement process, an omit map of Glu194 showed two nearby positive F o À F c electron density peaks of 5.5 s, one of which represented the WT side-chain con®guration. A water molecule modeled in the other peak did not have hydrogen-bonding partners whereas selection of another side-chain rotamer for Glu194 ®t into the electron density and provided hydrogen-binding partners. However, subsequent 2F o À F c electron density maps of this alternate conformation developed a break at the CB position. We suggest that an alternate conformation for this residue might exist that forms a 3.04 A Ê hydrogen bond to the backbone oxygen of Ala126, normally hydrogenbonded to the guanidinium head group of the conserved Arg134. It was shown that the Arg134-His mutant increases the pK a of the proton release group in O by 0.6 units, 35 so that the pH dependence of the fraction of O is displaced in R134H compared to WT BR, similar to the E194D mutant. Hence, it is plausible that the alternate conformation would allow Arg134 to couple directly to the proton release group. The proton release group is likely to consist of a polarizable hydrogen bonded network and not a single residue, such as Glu194 or Glu204. 36 Associated with the large helical displacements in the extracellular region, we note a unique interaction between two tryptophan side-chains on the extracellular side. Unlike in the WT structure, where Tyr83-OH (helix C) accepts a hydrogen bond from Trp189-NE1 (helix F), Tyr83-OH forms a 2.58 A Ê hydrogen bond with the backbone carbonyl of Ile119 (helix D). The Met118-CA (helix D) deviates from the WT position by 0.59 A Ê and Gly120 (helix D) by 1.08 A Ê . This change accounts for the tilt of helix D 3.6 relative to WT but it does not disrupt its helicity. As a result, the indole ring of Trp189 is rotated about both w 1 and w 2 , and Trp138 (helix E) is rotated 100 about w 1 ( Figure 6 ). Trp138-NE1, hydrogen bonded to Ala186-O (helix F) in the WT, is now bonded to Gly122-O. The Trp189 indole nitrogen forms a 3.20 A Ê p-cloud hydrogen bond 72 to the plane of the benzene moiety of the Trp138 indole ring, forming the edge-to-face motif that has recently been described. 37 It appears that the con®gurational change of these two bulky side-chains (which are, along with Tyr83, conserved in HR) is linked to the large motions seen in the extracellular region and notably to the large displacement of helix E. Thermodynamic studies on late photointermediates have shown that large protein motions are present not only in M and N, but also in the O intermediate. 38 It is unlikely that large-scale displacements on the cytoplasmic side would be present in the O intermediate, as these helices are thought to have reversed in the N 3 O transition already. 39 As mentioned in the previous section, the large structural changes in D85S on the extracellular side, but not on the cytoplasmic side, are consistent with the known properties of the O intermediate.
Cytoplasmic region
The region around Asp96 is nearly identical with the WT, suggesting that this residue is protonated in D85S also. Infrared titration had indicated that this is so for the blue species of D85N. 40 The channel between Asp96 and the cytoplasmic bulk solvent is closed, and water molecules 501 and 502 are in their WT positions. As in the WT, in D85S the Ala215-C1O hydrogen-bonds to water 501 (3.02 A Ê ) which bonds to Trp182-NE1 (2.91 A Ê ), the p-bulge at Ala215 in helix G is present, and water 502 bridges helices B and G via Thr46-C1O (3.28 A Ê ) and Lys216-C1O (3.31 A Ê ). Asp96-OD1 forms a 2.78 A Ê hydrogen bond to Thr46-OG1 similar to the WT structure ( Figure 7) . Suggestively, however, there is a small network of ordered water molecules in contact with the bulk solvent that resides above Phe42 (Figure 7) , a residue that appears to act as a barrier between these water molecules and Asp96. A second cluster of ®ve water molecules exists bridging helices A/B and G via Lys30, Tyr43, Leu-224 and Ser226. If these features of the D85S structure exist in O, these water molecules, along with salt bridge interactions (Glu232/Arg227 and Glu166/Arg164) and other intermolecular hydrogen bonds are very likely to be involved in reprotonating Asp96 in the N 3 O photocycle reaction. This would be possible if the outer section of the cytoplasmic half-channel opened up upon deprotonation of Asp96 in the M 3 N reaction, and subsequently Phe42 were to swing away from Asp96 allowing for its reprotonation via the water molecules in Figure 7 . With Phe42 out of the way, there would be a pathway for conducting a proton to Asp96, or alternatively, because in D85S and in HR it is a chloride ion that passes here, a pathway for the egress of an anion. shows the WT con®guration for these two residues. In the D85S model (b), the b-ionone ring of the retinal is pointing towards the benzene moiety of Trp189. Trp189 is pointing its NE1 towards the Trp138 benzene moiety forming a p-cloud hydrogen-bond (green dots). The positional shifts of these bulky residues are likely to be involved in the large motions of helices observed in the region.
Common pump mechanism for BR and HR
Traditionally, BR has been described as pumping protons (cations) to the extracellular side, and HR as pumping halides (anions) to the cytoplasmic side. Experiments that convert the function of BR to HR, and that of HR to BR, suggest a common mechanism for ion transport in both pumps. When the Schiff base counter ion Asp85 of BR is neutralized at low pH, BR transports Cl À towards the cytoplasmic side. 41 Similarly, single mutations that remove the Schiff base counter ion (D85S or D85T) convert BR into a chloride pump with HR-like photochemical reactions. 20 Thus it appears that the formation of an anion-binding site in BR is suf®-cient to confer chloride pumping and anion-dependent spectroscopic properties at physiological pH to BR. 42 On the other hand, in the presence of azide, the halide pump HR has been shown to transport protons to the extracellular side (or OH À to the cytoplasmic side). 43 The position of the chloride ion in the halorhodopsin crystal structure coincides with that of the OD1 atom of Asp85 in WT BR. 27 It is commonly assumed that Schiff base isomerization in HR reorients the NH chargedipole from an extracellular to a cytoplasmic direction, causing the mobile Cl À to be repulsed by anionic Asp238 (Asp212 in BR) on the extracellular side and simultaneously attracted by the protonated Schiff base on the cytoplasmic side via an ion/charge-dipole interaction 27, 29, 44 In D85S BR, chloride transport is likely to occur via a very similar mechanism since Asp212 (Asp238 in HR) is present to repulse a chloride bound near Ser85 once the Schiff base charge dipole has reoriented to point toward the cytoplasmic side. In WT BR, proton pumping is commonly thought to occur via proton transfer from the Schiff base to anionic Asp85, a process that would differ greatly from anion pumping in HR. However, an alternate pumping mechanism for WT BR proposes that it, like HR, also pumps anions, namely in the form of hydroxide ions, from the extracellular to the cytoplasmic side. In response to the light-driven Schiff base isomerization and the resulting charge separation, Asp85 would abstract a proton from water 402, generating a mobile hydroxide anion. 29 With Asp212 repulsing this hydroxide, and the cytoplasmic-facing charge-dipole of the protonated Schiff base attracting it, anion (OH À ) transport from the extracellular to the cytoplasmic side of the Schiff base would occur, analogous to the chloride pumping mechanism of halorhodopsin. Unlike in the case of Cl À pumping, where the Schiff base remains protonated throughout the photocycle, the strong base OH À would abstract the Schiff base proton upon arrival at the cytoplasmic side, giving rise to the M intermediate. Another fundamental difference occurs in the O to BR transition, the least reversible and, with a possible exception of the N 3 O transition, the slowest step of the photocycle: in the proton-pumping scheme, a relatively simple transfer of one proton from Asp85 to the proton release group is required. In the anion-pumping scheme, a chloride or hydroxide would have to move from near the extracellular side, past Arg82, to the region of the Schiff base (Figure 8 ).
Structural similarities between HR and the BR D85S structure presented here are dif®cult to describe because this D85S structure does not contain chloride. However, we can make simple assumptions regarding D85S chloride binding near the Schiff base. Unlike HR, where Arg108 is saltlinked to CL501, Arg82 in BR D85S is oriented towards the extracellular side. Upon chloride binding, it is likely that helix B, which contains Arg82 and Ser85, would move to allow the large chloride anion to ®t near the Schiff base. Furthermore, Arg82 would likely face towards the Schiff base to provide a counter-charge to the chloride anion similarly to what is observed in HR. A possible explanation for the``open'' state of the extracellular region observed here is that since the cytoplasmic side of the D85S structure is closed, the initial chloride binding likely occurs from the extracellular region. Other differences between HR and BR (in parentheses) include the lack of chloride coordination ligands Val72 (Ile52), Ser73 (Ala53), and WAT512. We are currently working on improving the crystals of D85S BR in the presence of chloride in order to obtain the chloride-bound structure of this mutant. We expect that this and subsequent photointermediate structures will aid in understanding the detailed pump mechanism of these closely related proteins.
Materials and Methods
Site directed mutagenesis The D85S mutant, described previously, 19 and the D85S/F219L double mutant were both constructed using site-directed mutagenesis of bop (BR gene, GenBank accession AE005062) by hybridizing two mutagenic primers with single-stranded DNA containing bop and a mutant Amp s gene. The ®rst mutagenic primer was for bop and the second encoded an Amp s 3 Amp r . The primers were extended by T4 DNA polymerase, and after the addition of T4 DNA ligase, were electroporated into a mutS strain with selection for Amp r . The transformants were pooled, DNA isolated, and the mixture transformed into JM109. After sequencing a BamHI-HindIII fragment containing bop it was cloned into vector pNovr, which has a pHH9 H. halobium replicating origin, the Escherichia coli tetracycline resistance gene (Tet r ), and the H. volcanii novobiocin resistance gene (Nov r , kindly provided by M.L. Holmes). H. halobium transformants were selected on plates containing 0.3 mg ml À1 of novobiocin. Novobiocin was used only when growing the starter cul- Figure 8 . Schematic representation of the bacteriorhodopsin transport mechanism. The extracellular medium is in the downward direction. Three states are shown, (A) the BR or resting state, (B) the M photointermediate, and (C) an O-like state, to illustrate the most important changes in the extracellular and the cytoplasmic regions. In M, on the extracellular side, downward movement of the side-chain of Arg82 in response to rearrangements at the Schiff base causes the release of a proton to the extracellular surface. Reprotonation of the retinal Schiff base by Asp96 is facilitated by a conformational change and the formation of a hydrogen-bonded chain of water molecules in the cytoplasmic region. To close the cycle, a proton has to be translocated from Asp85 to the proton release group, or, in the anion pumping scheme, a chloride or hydroxide ion must move from that region toward the Schiff base. The latter mechanism would be expected to require much larger conformational changes (and thus be slower) to allow the anion to pass Arg82. ture, and it was not included in the medium when growing one-liter production cultures.
Purification and crystallization of mutant proteins
Both mutant proteins form membrane patches, which are blue at low halide ion concentration, and can be isolated similarly to WT BR in the form of purple membrane. 45 DNase-treated cells are lysed by two successive cycles of dialysis of resuspended cell paste for 16-24 hours at 4 C. The buffer used for dialysis is 0.58 % (w/ v) NaCl, the volume ratio of cell slurry to dialysis buffer is 1:40. Following centrifugation at 150,000 g for 30 minutes, the pellet is washed a minimum of three times against 0.58 % NaCl and 0.02 % (w/v) sodium azide. Subsequent sucrose gradient puri®cation is followed by a ®vefold dilution with water and then centrifugation at 150,000 g for 30 minutes.
The D85S mutant protein was solubilized by resuspending pellets of blue membrane in 25 mM K/Na phosphate buffer at pH 6.9, containing 1.2 % octyl-b-Dglucopyranoside at a detergent:protein ratio of 20:1. After incubation in the dark at 20 C for 16-18 hours, the pH was adjusted to 5.6 with 0.1 M HCl in 25 mM K/Na phosphate solution, containing 1.2 % OG. The D85S/ F219L double mutant was solubilized with the same buffer, but with the initial pH adjusted to 5.6 to improve protein stability, although this results in considerably less ef®cient solubilization. Excess retinal was also added to the solubilization buffer (and to the crystallization setup) as dry reagent, in order to further stabilize the native protein. In both cases, the solution of solubilized protein was then centrifuged at 150,000 g for 30 minutes to remove undissolved material, and then concentrated to 20-30 mg ml À1 . The detergent-solubilized protein was used for crystallization via cubic lipid phase crystallization, as originally described. 2 The concentrated protein solution was added to the monoolein at a ratio of approximately 35:65 protein-solution:MO (w/w). No other buffer or additives were used to crystallize the blue protein. After addition of the concentrated protein solution, the samples were centrifuged at 22 C and 10,000 g, either with or without rotation every 15 minutes, for a total of about 100 minutes, in order to form a uniformly blue hydrated gel.
Needle-shaped crystals of the D85S mutant protein form overnight, and they reach their full size in less than one month. The crystals vary in size from 10 to 200 mm in length, and 5-30 mm in thickness. The D85S/F219L double mutant forms both needle-shaped and¯at-plate crystals. The needles grew to a length of 80-120 mm and a thickness of 5-10 mm, while the plates were typically 150 mm long, 50 mm wide, and $5 mm thick.
Data collection
Mature crystals were removed from the cubic phase gel by mechanical extraction,¯ash-cooled in liquid N 2 , and mounted in a loop for data collection. Diffraction data were collected at the Lawrence Berkeley National Laboratory Advanced Light Source (ALS) beam line 5.0.2, using a 100 mm ®xed-pinhole collimator, and at the Stanford Synchrotron Radiation Laboratory (SSRL) beam line 9.1, using 150 mm slits on the collimator. Individual data sets, consisting of 60-90 frames, were collected with 1 oscillations. Data reduction and scaling were performed with Denzo and Scalepack. 46 a R sym [AE h AE i jI(h, i) À hI(h)ij/AE h AE i jI(h, i)j] Â 100 %, where I(h,i) is the intensity value of the ith measurement of h and hI(h)i is the corresponding mean value of h for all I measurements of h. The summation is over all measurements.
b R-value (AEjF o À F c j/AEjF o j) Â 100 %. c R free was calculated by omitting 5 %, picked randomly within thin resolution shells, of the observed re¯ections from re®nement and R-factor calculation.
Molecular replacement, modeling and refinement
The 2.3 A Ê WT BR coordinates (1BRX 47 ) were used as the search model for molecular replacement (X-PLOR 48 ) against the D85S orthorhombic data set. The initial R-factors for the D85S model after rigid body re®nement were R 42.8 % and R free 41.1 % (8-3 A Ê ) in X-PLOR. Successive rounds of model building (O v.7 49 ) and re®nement (CNS 1.0 50 ) were performed until convergence. In addition to 3F o À 2F c and F o À F c electron density maps, composite-annealed omit maps (omitting 5 % of the model) were used extensively and it became evident that the extracellular region of the protein had substantially changed from the ground state structure. Lipids were modeled in the late stages of re®nement; however most chains were incomplete or suffered from extensive chain breaks spanning two or more carbon atoms, leaving positive difference peaks not modeled. Water molecules were manually placed using standard distance and angle constraints. No other solvent molecules could be identi®ed in the D85S structure. The ®nal R-factor is 21.3 % and the R free is 24.5 %, with 97.8 % of the main-chain in the most favored regions of the Ramachandran plot and 2.2 % in the allowed regions. Other statistics are summarized in Table 2 .
For the D85S/F219L data set, a re®ned protein-only model of D85S was used as the starting model and R-factors below 30 % were obtained immediately. An omit map of residue 219 clearly showed the F219L mutation. Composite-annealed omit maps, 3F o À 2F c and F o À F c maps were also used in model rebuilding. The ®nal Rfactor is 22.2 % and the R-free is 24.0 %, with 97.8 % of the main-chain in the most favored regions of the Ramachandran plot and 2.2 % in the allowed regions. With the exception of a rearrangement at the G helix p-bulge near the mutation, this double mutant structure con®rms all the features of the D85S structure, with the addition that the DE loop, which is disordered in the D85S electron density maps, is ordered in this structure.
Coordinates
Atomic coordinates for the D85S and D85S/F219L have been deposited with the Protein Data Bank for immediate release (accession code 1JV7 and 1JV6, respectively).
